ArticleLaryngoscope investigative otolaryngology2025
Collagen Matrix Combined With Hydroxyapatite and Nasoseptal Flap for Skull Base Reconstruction.
Article in Laryngoscope investigative otolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Osteogenic Potential of 3D Bioprinted Collagen Scaffolds Enriched with Bone Marrow Stromal Cells, BMP-2, and Hydroxyapatite in a Rabbit Calvarial Defect Model.Journal of functional biomaterials · 2026Article
- Collagen Matrix Combined With Hydroxyapatite and Nasoseptal Flap for Skull Base Reconstruction.Laryngoscope investigative otolaryngology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Extended endoscopic endonasal transsphenoidal approaches (ExEETSA) commonly result in high-flow cerebrospinal fluid (CSF) leaks that demand robust reconstruction strategies. Although nasoseptal flap (NSF) is a standard reconstructive technique, high-flow grade 3 CSF leaks require additional rigid reconstruction. This study evaluated the long-term outcomes of collagen matrix-hydroxyapatite (HXA)-NSF for rigid skull base reconstruction without lumbar drain. Methods: A retrospective cohort study was conducted on 100 patients undergoing ExEETSA involved intraoperative high-flow grade 3 CSF leak that were managed using a collagen matrix for dural repair followed by HXA and NSF reconstruction without lumbar drainage between January 2016 and December 2023. The primary outcomes assessed were postoperative CSF leakage, meningitis, and HXA-related complications. Results: The median skull base defect diameter was 22.9 mm. Tuberculum sellae meningioma represented the predominant pathology (39.0%), with the transplanum/transtuberculum region being the most commonly affected area (77.0%). Postoperative CSF leakage occurred in 4% of cases. HXA exposure accompanied by partial NSF necrosis was observed in eight patients (8.0%). Of these, complete re-mucosalization of the exposed HXA surface was achieved in five patients (62.5%), with a mean healing time of 23.6 months. There were no cases of meningitis or local infection requiring reoperation. Conclusion: The combination of collagen matrix, HXA, and NSF without lumbar drainage represents a safe and effective reconstruction strategy for managing intraoperative high-flow Grade 3 CSF leaks in ExEETSA. This reconstructive technique yielded favorable outcomes, characterized by a low incidence of postoperative CSF leakage, manageable complications, and sustained long-term effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.